Literature DB >> 26504097

Diagnosis and management of testosterone deficiency syndrome in men: clinical practice guideline.

Alvaro Morales1, Richard A Bebb2, Priya Manjoo2, Peter Assimakopoulos2, John Axler2, Christine Collier2, Stacy Elliott2, Larry Goldenberg2, Irv Gottesman2, Ethan D Grober2, Gordon H Guyatt2, Daniel T Holmes2, Jay C Lee2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26504097      PMCID： PMC4674408          DOI： 10.1503/cmaj.150033

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  26 in total

1.  Studies on prostatic cancer. I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. 1941.

Authors:  Charles Huggins; Clarence V Hodges
Journal:  J Urol       Date:  2002-02       Impact factor: 7.450

2.  Identification of late-onset hypogonadism in middle-aged and elderly men.

Authors:  Frederick C W Wu; Abdelouahid Tajar; Jennifer M Beynon; Stephen R Pye; Alan J Silman; Joseph D Finn; Terence W O'Neill; Gyorgy Bartfai; Felipe F Casanueva; Gianni Forti; Aleksander Giwercman; Thang S Han; Krzysztof Kula; Michael E J Lean; Neil Pendleton; Margus Punab; Steven Boonen; Dirk Vanderschueren; Fernand Labrie; Ilpo T Huhtaniemi
Journal:  N Engl J Med       Date:  2010-06-16       Impact factor: 91.245

Review 3.  AGREE II: advancing guideline development, reporting and evaluation in health care.

Authors:  Melissa C Brouwers; Michelle E Kho; George P Browman; Jako S Burgers; Francoise Cluzeau; Gene Feder; Béatrice Fervers; Ian D Graham; Jeremy Grimshaw; Steven E Hanna; Peter Littlejohns; Julie Makarski; Louise Zitzelsberger
Journal:  CMAJ       Date:  2010-07-05       Impact factor: 8.262

4.  GRADE: an emerging consensus on rating quality of evidence and strength of recommendations.

Authors:  Gordon H Guyatt; Andrew D Oxman; Gunn E Vist; Regina Kunz; Yngve Falck-Ytter; Pablo Alonso-Coello; Holger J Schünemann
Journal:  BMJ       Date:  2008-04-26

5.  Adverse events associated with testosterone replacement in middle-aged and older men: a meta-analysis of randomized, placebo-controlled trials.

Authors:  Olga M Calof; Atam B Singh; Martin L Lee; Anne M Kenny; Randall J Urban; Joyce L Tenover; Shalender Bhasin
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2005-11       Impact factor: 6.053

Review 6.  Cardiovascular risk associated with testosterone-boosting medications: a systematic review and meta-analysis.

Authors:  Giovanni Corona; Elisa Maseroli; Giulia Rastrelli; Andrea M Isidori; Alessandra Sforza; Edoardo Mannucci; Mario Maggi
Journal:  Expert Opin Drug Saf       Date:  2014-08-19       Impact factor: 4.250

Review 7.  Testosterone supplementation in heart failure: a meta-analysis.

Authors:  Mustafa Toma; Finlay A McAlister; Erin E Coglianese; Venkatesan Vidi; Samip Vasaiwala; Jeffrey A Bakal; Paul W Armstrong; Justin A Ezekowitz
Journal:  Circ Heart Fail       Date:  2012-04-17       Impact factor: 8.790

8.  Correlates of low testosterone and symptomatic androgen deficiency in a population-based sample.

Authors:  Susan A Hall; Gretchen R Esche; Andre B Araujo; Thomas G Travison; Richard V Clark; Rachel E Williams; John B McKinlay
Journal:  J Clin Endocrinol Metab       Date:  2008-07-29       Impact factor: 5.958

Review 9.  The diagnosis of late life hypogonadism.

Authors:  John E Morley
Journal:  Aging Male       Date:  2007-12       Impact factor: 5.892

10.  Testosterone therapy during exercise rehabilitation in male patients with chronic heart failure who have low testosterone status: a double-blind randomized controlled feasibility study.

Authors:  Martin Stout; Garry A Tew; Helen Doll; Irena Zwierska; Nicola Woodroofe; Kevin S Channer; John M Saxton
Journal:  Am Heart J       Date:  2012-10-30       Impact factor: 4.749
View more
  24 in total

1.  Controversies in the diagnosis and management of testosterone deficiency syndrome.

Authors:  Geoffrey I Hackett
Journal:  CMAJ       Date:  2015-10-26       Impact factor: 8.262

2.  Addressing the pressing issues related to testosterone administration to men with prostate cancer.

Authors:  Alvaro Morales
Journal:  Can Urol Assoc J       Date:  2016 May-Jun       Impact factor: 1.862

Review 3.  Aging and sex hormones in males.

Authors:  Maria Chiara Decaroli; Vincenzo Rochira
Journal:  Virulence       Date:  2016-11-10       Impact factor: 5.882

Review 4.  Predicting low testosterone in aging men: a systematic review.

Authors:  Adam C Millar; Adrian N C Lau; George Tomlinson; Alan Kraguljac; David L Simel; Allan S Detsky; Lorraine L Lipscombe
Journal:  CMAJ       Date:  2016-06-20       Impact factor: 8.262

5.  Testosterone and prostate health: Have the paradigms truly shifted?

Authors:  Alvaro Morales; D Robert Siemens
Journal:  Can Urol Assoc J       Date:  2020-08       Impact factor: 1.862

6.  Testosterone use causing erythrocytosis.

Authors:  Andrea Cervi; Amaris K Balitsky
Journal:  CMAJ       Date:  2017-10-16       Impact factor: 8.262

Review 7.  Paediatric and adult-onset male hypogonadism.

Authors:  Andrea Salonia; Giulia Rastrelli; Geoffrey Hackett; Stephanie B Seminara; Ilpo T Huhtaniemi; Rodolfo A Rey; Wayne J G Hellstrom; Mark R Palmert; Giovanni Corona; Gert R Dohle; Mohit Khera; Yee-Ming Chan; Mario Maggi
Journal:  Nat Rev Dis Primers       Date:  2019-05-30       Impact factor: 52.329

8.  Gonadal Hormones in the Pathogenesis and Treatment of Bone Health in Patients with Chronic Kidney Disease: a Systematic Review and Meta-Analysis.

Authors:  Jasna Aleksova; Alexander J Rodriguez; Robert McLachlan; Peter Kerr; Frances Milat; Peter R Ebeling
Journal:  Curr Osteoporos Rep       Date:  2018-12       Impact factor: 5.096

9.  Testosterone therapy: Prescribing and monitoring patterns of practice in British Columbia.

Authors:  Jennifer A Locke; Ryan Flannigan; Oliver P Günther; Sean Skeldon; S Larry Goldenberg
Journal:  Can Urol Assoc J       Date:  2021-02       Impact factor: 1.862

Review 10.  Recommendations for followup of stage I and II seminoma: The Princess Margaret Cancer Centre approach.

Authors:  Hester Lieng; Padraig Warde; Philippe Bedard; Robert J Hamilton; Aaron R Hansen; Michael A S Jewett; Martin O'malley; Joan Sweet; Peter Chung
Journal:  Can Urol Assoc J       Date:  2017-12-01       Impact factor: 1.862
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.